8-KItem 2.02 · Results of OperationsItem 8.01 · Other EventsItem 9.01 · Financial Statements
Quest Diagnostics ($DGX) filed an 8‑K (Item 2.02) on Feb 10, 2026 announcing Q4 and full‑year results for…
Filed with the SEC on · Summarized by InvestorsBot
Quest Diagnostics ($DGX) filed an 8‑K (Item 2.02) on Feb 10, 2026 announcing Q4 and full‑year results for the period ended Dec 31, 2025; press release attached as Exhibit 99.1. Investors should review for revenue, EPS and guidance updates. 📢 #Earnings #Diagnostics
The press release is incorporated by reference in the 8‑K and reports results of operations and financial condition for FY2025/Q4 2025. Exhibit 99.1 is available on the SEC filing and company website. $DGX 🔍 #Healthcare #FY2025